Search Results for compound

Matched iupac: … trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen ... (2S,3S,4S,5R,6S)-6-[(3-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5- ... -7-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid …

Matched iupac: … 6-{[4,4,6a,6b,11,11,14b-heptamethyl-8a-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4,4a ... yl]oxy}-4-hydroxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxane-2-carboxylic acid ... 7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl]oxy}-3-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2- …

Matched synonyms: … 1-18:0-2-18:2-Atidate ... 1-18:0-2-18:2-Atidic acid ... PA(36:2) …
Matched name: … PA(18:0/18:2(9Z,12Z)) …
Matched iupac: … [(2R)-2-(octadeca-9,12-dienoyloxy)-3-(octadecanoyloxy)propoxy]phosphonic acid …
Matched description: … PA(18:0/18:2(9Z,12Z)), in particular, consists of one chain of stearic acid at the C-1 position and one ... PA(18:0/18:2(9Z,12Z)) is a phosphatidic acid. ... chain of linoleic acid at the C-2 position. …

Matched description: … at positions 2, 3 and 4 respectively. ... These are alkylamines in which the alkyl group is substituted at one carbon atom by an aromatic hydrocarbyl ... A dicarboxylic acid that is pyrole bearing aminomethyl, carboxymethyl and 2-carboxyethyl substituents …

Matched iupac: … 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E)-3-oxooct-1-en-1-yl]cyclopentyl]-6-oxoheptanoic acid …
Matched description: … caused by thromboxane A(2). ... Prostacyclin (PGI2) is one of the major vascular protectors against thrombosis and vasoconstriction, ... important cardioprotective role increasingly appreciated in recent years in light of adverse effects of COX-2 …

Matched iupac: … N-(3-hydroxy-1-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl)icosanamide …
Matched description: … a sphingolipid with one carbohydrate moiety attached to a ceramide unit. ... In infants, the disease is generally fatal before age 2. ... Symptoms begin between the ages of 3 and 6 months with irritability, fevers, limb stiffness, seizures …

Matched iupac: … N-(3-hydroxy-1-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl)tetradecanamide …
Matched description: … a sphingolipid with one carbohydrate moiety attached to a ceramide unit. ... In infants, the disease is generally fatal before age 2. ... Symptoms begin between the ages of 3 and 6 months with irritability, fevers, limb stiffness, seizures …

Matched iupac: … methyl (2R,3E,4S)-4-{2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl}-3-ethylidene-2-hydroxy-3,4-dihydro …

Matched synonyms: … 1-Palmitoyl-2-oleoyl-sn-glycero-3-oethanolamine-N,N-dimethyl ... 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine-N,N-dimethyl …
Matched iupac: … [2-(dimethylamino)ethoxy][(2R)-3-(hexadecanoyloxy)-2-(octadec-9-enoyloxy)propoxy]phosphinic acid …
Matched description: … many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 …

Matched iupac: … [2-(icosanoyloxy)-3-[(9Z)-octadec-9-enoyloxy]propoxy][2-(methylamino)ethoxy]phosphinic acid …

Matched synonyms: … Uridine dio-2-acetamido-2-deoxy-D-galactose ... Uridine dio-2-acetamido-2-deoxy-delta-galactose ... Uridine diphospho-2-acetamido-2-deoxy-D-galactose …
Matched iupac: … )oxy]({[3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})phosphinic acid ... [({[5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl …
Matched description: … positive and negative correlations between GFAT activity in human muscle tissue from patients with type 2 ... hyperglycemia-induced insulin resistance are scarce and restricted to measurements of glutamine fructose-6- …

Matched iupac: … -8a-({[(2Z)-2-methylbut-2-enoyl]oxy}methyl)-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen ... }-3-hydroxy-5-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxane-2-carboxylic acid ... (2S,3S,4S,5R)-6-{[(3S,4S,4aR,6aR,6bS,8R,8aS,9S,12aS,14aR,14bR)-4-formyl-8,9-dihydroxy-4,6a,6b,11,11,14b-hexamethyl ... -3-yl]oxy}-4-{[(2S,4S,5S)-4,5-dihydroxy-3-{[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy …

Matched name: … CL(18:1(11Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:3(6Z,9Z,12Z)) …
Matched iupac: … [2-hydroxy-3-({hydroxy[(2R)-3-[(11Z)-octadec-11-enoyloxy]-2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propoxy ... ]phosphoryl}oxy)propoxy][(2R)-2-[(6Z,9Z,12Z)-octadeca-6,9,12-trienoyloxy]-3-[(9Z,12Z)-octadeca-9,12-dienoyloxy …

Matched name: … CL(18:1(11Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:3(9Z,12Z,15Z)) …
Matched iupac: … [2-hydroxy-3-({hydroxy[(2R)-3-[(11Z)-octadec-11-enoyloxy]-2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propoxy ... ]phosphoryl}oxy)propoxy][(2R)-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyloxy]-3-[(9Z,12Z)-octadeca-9,12 …

Matched name: … CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/20:1(13Z)) …
Matched iupac: … [(2R)-2,3-bis[(9Z,12Z)-octadeca-9,12-dienoyloxy]propoxy][2-hydroxy-3-({hydroxy[(2R)-2-[(13Z)-icos-13- …

Matched name: … CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/22:1(13Z)) …
Matched iupac: … [(2R)-2,3-bis[(9Z,12Z)-octadeca-9,12-dienoyloxy]propoxy][3-({[(2R)-2-[(13Z)-docos-13-enoyloxy]-3-[(9Z ... ,12Z,15Z)-octadeca-9,12,15-trienoyloxy]propoxy](hydroxy)phosphoryl}oxy)-2-hydroxypropoxy]phosphinic acid …

Matched iupac: … (4R,6S)-4,12,12-trimethyl-9-methylidene-5-oxatricyclo[8.2.0.0^{4,6}]dodecane …

Matched iupac: … (4R,6R)-4,12,12-trimethyl-9-methylidene-5-oxatricyclo[8.2.0.0^{4,6}]dodecane …

Matched description: … 2e,6e-farnesol, also known as 2-trans,6-trans-farnesol or (2e,6e)-3,7,11-trimethyl-2,6,10-dodecatrien …

Matched synonyms: … N-[2,4-Dichloro-5-[4-(difluoromethyl)-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phenyl]methanesulfonamide …
Matched iupac: … N-{2,4-dichloro-5-[4-(difluoromethyl)-3-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]phenyl}methanesulfonamide …

Matched iupac: … N-(3-hydroxy-1-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl)docosanamide …
Matched description: … a sphingolipid with one carbohydrate moiety attached to a ceramide unit. ... In infants, the disease is generally fatal before age 2. ... Symptoms begin between the ages of 3 and 6 months with irritability, fevers, limb stiffness, seizures …

Matched iupac: … 2-[(2-{[5,16-dihydroxy-14-(2-hydroxy-6-methylhept-5-en-2-yl)-2,6,6,10,11-pentamethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵ ... ]heptadecan-8-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl)oxy]oxane-3,4,5-triol …

Matched iupac: … 2-{[4,5-dihydroxy-6-(hydroxymethyl)-2-{[18-(2-hydroxypropan-2-yl)-2,6,6,10,16-pentamethyl-17,21,23-trioxaheptacyclo ... [20.2.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0¹⁵,²².0¹⁶,²⁰]pentacosan-7-yl]oxy}oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol …

Matched iupac: … -one ... (2E)-1-[2-hydroxy-3-(2-hydroxy-3-methylbut-3-en-1-yl)-4-methoxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1 …

Matched iupac: … 6-{[4,4,6a,6b,11,12,14b-heptamethyl-8a-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4,4a ... ,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic …